AlzChem Group Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Andreas Niedermaier

Chief executive officer

€1.5m

Total compensation

CEO salary percentage	20.9%
CEO tenure	13.1yrs
CEO ownership	n/a
Management average tenure	7yrs
Board average tenure	11.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Andreas Niedermaier's remuneration changed compared to AlzChem Group's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	€50m
Jun 30 2024	n/a	n/a	€46m
Mar 31 2024	n/a	n/a	€39m
Dec 31 2023	€2m	€315k	€35m
Sep 30 2023	n/a	n/a	€30m
Jun 30 2023	n/a	n/a	€28m
Mar 31 2023	n/a	n/a	€30m
Dec 31 2022	€818k	€315k	€30m
Sep 30 2022	n/a	n/a	€29m
Jun 30 2022	n/a	n/a	€28m
Mar 31 2022	n/a	n/a	€27m
Dec 31 2021	€890k	€300k	€28m
Sep 30 2021	n/a	n/a	€27m
Jun 30 2021	n/a	n/a	€26m
Mar 31 2021	n/a	n/a	€23m
Dec 31 2020	€786k	€300k	€20m
Sep 30 2020	n/a	n/a	€16m
Jun 30 2020	n/a	n/a	€17m
Mar 31 2020	n/a	n/a	€17m
Dec 31 2019	€915k	€260k	€18m
Sep 30 2019	n/a	n/a	€19m
Jun 30 2019	n/a	n/a	€18m
Mar 31 2019	n/a	n/a	€20m
Dec 31 2018	n/a	n/a	€23m
Sep 30 2018	n/a	n/a	€22m
Jun 30 2018	€453k	€110k	€32m
Mar 31 2018	n/a	n/a	€21m
Dec 31 2017	€1m	€220k	€20m

Compensation vs Market: Andreas's total compensation ($USD1.59M) is about average for companies of similar size in the German market ($USD1.42M).

Compensation vs Earnings: Andreas's compensation has increased by more than 20% in the past year.

CEO

Andreas Niedermaier (55 yo)

13.1yrs

Tenure

€1,509,000

Compensation

Mr. Andreas Niedermaier has been Chairman of Executive Board & Chief Executive Officer at AlzChem Group AG since July 01, 2019 and has been its Member of Management Board since October 20, 2011. He served...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Andreas Niedermaier	CEO & Chairman of Executive Board	13.1yrs	€1.51m	no data
Klaus Englmaier	Member of Executive Board & COO	8.8yrs	€1.24m	no data
Georg Weichselbaumer	Chief Sales Officer & Member of Executive Board	5.3yrs	€1.24m	no data
Andreas Losle	CFO & Member of Management Board	less than a year	no data	no data

7.0yrs

Average Tenure

59yo

Average Age

Experienced Management: ACT's management team is seasoned and experienced (7 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Markus Zöllner	Chairman of the Supervisory Board	15.1yrs	€42.00k	no data
Martina Heigl-Murauer	Independent Member of the Supervisory Board	8yrs	€24.00k	no data
Caspar von Schnurbein	Deputy Chairman of the Supervisory Board	8yrs	€32.00k	no data
Steve Röper	Member of the Supervisory Board	15.1yrs	€22.00k	no data

11.5yrs

Average Tenure

53.5yo

Average Age

Experienced Board: ACT's board of directors are seasoned and experienced ( 11.5 years average tenure).

AlzChem Group Management

Management criteria checks 3/4

Key information

Recent management updates

AlzChem Group AG, Annual General Meeting, May 11, 2023

Recent updates

Third quarter 2024 earnings released: EPS: €1.22 (vs €0.85 in 3Q 2023)

AlzChem Group AG to Report Fiscal Year 2024 Results on Feb 28, 2025

Price target increased by 13% to €71.78

Price target increased by 7.7% to €66.03

Investor sentiment improves as stock rises 20%

Now 23% overvalued

Investor sentiment deteriorates as stock falls 16%

Price target increased by 13% to €61.30

Price target increased by 7.5% to €56.05

Second quarter 2024 earnings released: EPS: €0.71 (vs €0.70 in 2Q 2023)

AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024

Price target increased by 9.4% to €54.05

New minor risk - Share price stability

Price target increased by 15% to €49.40

AlzChem Group AG to Report First Half, 2024 Results on Aug 01, 2024

First quarter 2024 earnings released: EPS: €1.20 (vs €0.76 in 1Q 2023)

Investor sentiment improves as stock rises 17%

Dividend increased to €1.20

AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024

Price target increased by 7.9% to €37.35

Price target increased by 7.9% to €35.60

Price target increased by 9.1% to €34.63

AlzChem Group AG to Report Q1, 2024 Results on Apr 30, 2024

Price target increased by 9.3% to €33.00

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: €0.85 (vs €0.58 in 3Q 2022)

AlzChem Group AG to Report Fiscal Year 2023 Results on Mar 01, 2024

AlzChem Group AG to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment improves as stock rises 17%

New minor risk - Financial position

Second quarter 2023 earnings released: EPS: €0.71 (vs €0.95 in 2Q 2022)

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG to Report First Half, 2023 Results on Aug 03, 2023

Upcoming dividend of €1.05 per share at 5.5% yield

Price target increased by 8.7% to €29.58

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improved over the past week

AlzChem Group AG, Annual General Meeting, May 11, 2023

Price target decreased to €26.05

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG to Report Fiscal Year 2022 Final Results on Feb 28, 2023

Price target decreased to €26.05

AlzChem Group AG provides sales guidance For the fiscal year 2022

Second quarter 2022 earnings released: EPS: €0.95 (vs €0.90 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG Approves Dividend

Upcoming dividend of €1.00 per share

AlzChem Group AG Increasing Its Sales Forecast for the Fiscal Year 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

AlzChem Group AG Proposes Dividend for the Year 2021

Third quarter 2021 earnings released: EPS €0.46 (vs €0.37 in 3Q 2020)

Price target increased to €32.25

Second quarter 2021 earnings released: EPS €0.66 (vs €0.66 in 2Q 2020)

AlzChem Group AG Revises Earnings Guidance for the Year 2021

AlzChem Group AG Resolves Dividend, Payable on May 18, 2021

First quarter 2021 earnings released

Upcoming dividend of €0.77 per share

AlzChem Group AG Revises Earnings Guidance for 2021

Full year 2020 earnings released: EPS €1.94 (vs €1.77 in FY 2019)

AlzChem Group AG Provides Consolidated Sales Guidance for the Full Year 2021

AlzChem Group AG Proposes Dividend for 2020

New 90-day high: €24.50

AlzChem Group AG to Report Fiscal Year 2020 Results on Mar 19, 2021

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: EPS €0.37

AlzChem Group AG Expands Nitrile Production by 50%

New 90-day low: €17.50

AlzChem Group AG Revises Consolidated Sales Guidance for the Fiscal Year 2020

AlzChem Group AG to Report First Half, 2021 Results on Aug 05, 2021

AlzChem Group AG to Report Q1, 2021 Results on May 06, 2021

Price target raised to €28.50

New 90-day high - €22.70

Earnings released

CEO Compensation Analysis